Direct and indirect costs associated with moderate and severe asthma in Quebec, Canada

Author:

Ismaila Afisi12,Blais Lucie3,Dang-Tan Tam1,Zhang Shiyuan4,Forget Amélie3,Kettani Fatima-Zohra3,Corriveau Diane5,Lemiere Catherine67,

Affiliation:

1. Value Evidence and Outcomes, GSK, Research Triangle Park, Raleigh-Durham, North Carolina, USA;

2. Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada;

3. Faculté de pharmacie, Université de Montréal, Québec, Canada;

4. Health Economics and Outcomes Research, GSK, Mississauga, Ontario, Canada;

5. Medical Affairs, GSK, Mississauga, Ontario, Canada;

6. Faculté de médecine, Université de Montréal, Montréal, Québec, Canada;

7. Centre intégré universitaire de santé et de services sociaux du Nord de l’Île de Montréal (CIUSSS), Montréal, Québec, Canada

Funder

GlaxoSmithKline

Publisher

Informa UK Limited

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study;Allergy, Asthma & Clinical Immunology;2024-02-04

2. A population-based study of the burden of severe asthma in Alberta, Canada;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2023-07-04

3. Economic burden of food allergy in Canada;Annals of Allergy, Asthma & Immunology;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3